Bradykinin Receptor Antagonists

Preferred Label : Bradykinin Receptor Antagonists;

MeSH definition : Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.;

MeSH synonym : Antagonists, Bradykinin Receptor; Receptor Antagonists, Bradykinin; Bradykinin Receptor Blockers; Receptor Blockers, Bradykinin; Bradykinin Receptor Inhibitors; Inhibitors, Bradykinin Receptor; Receptor Inhibitors, Bradykinin; Bradykinin Antagonists; Antagonists, Bradykinin; Bradykinin Antagonist; Antagonist, Bradykinin; Bradykinin Receptor Blocker; Blocker, Bradykinin Receptor; Receptor Blocker, Bradykinin; Bradykinin Receptor Antagonist; Antagonist, Bradykinin Receptor; Receptor Antagonist, Bradykinin; Bradykinin Receptor Inhibitor; Inhibitor, Bradykinin Receptor; Receptor Inhibitor, Bradykinin;

Is substance : O;

Details

Origin ID

D065168;

UMLS CUI

C3850094;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Bradykinin Receptor Antagonist [NCIt concept]
MeSH Descriptor(s) used for indexing
- receptors, bradykinin [MeSH Descriptor]
Record concept(s)
- Bradykinin Receptor Antagonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3-benzyl-1-(4-guanidinylphenyl)-4-phenyl-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- B 9430 [MeSH Supplementary Concept]
- B 9858 [MeSH Supplementary Concept]
- CP 0597 [MeSH Supplementary Concept]
- FR 165649 [MeSH Supplementary Concept]
- FR 167344 [MeSH Supplementary Concept]
- FR 173657 [MeSH Supplementary Concept]
- FR 184280 [MeSH Supplementary Concept]
- FR 193517 [MeSH Supplementary Concept]
- J 324 [MeSH Supplementary Concept]
- JMV 1640 [MeSH Supplementary Concept]
- LF 16-0687 [MeSH Supplementary Concept]
- LF 16.0335 [MeSH Supplementary Concept]
- MEN 11270 [MeSH Supplementary Concept]
- N-(4-(2-(2-((2-dmethylaminoethyl)methylamino)ethylaminocarbonyl)pyrrolidinylsulfonyl)-2-nitrophenylamino)-N'-diphenylmethylthiourea [MeSH Supplementary Concept]
- NPC 18521 [MeSH Supplementary Concept]
- NPC 18688 [MeSH Supplementary Concept]
- PsT-1 peptide, phyllomedusa sauvagei [MeSH Supplementary Concept]
- R 715 [MeSH Supplementary Concept]
- bradykinin, Lys-Leu(8)-desArg(9)- [MeSH Supplementary Concept]
- bradyzide [MeSH Supplementary Concept]
- deltibant [MeSH Supplementary Concept]
- helokinestatin [MeSH Supplementary Concept]
- martinellic acid [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Bradykinin Receptor Antagonist [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients